Two Sigma Securities’s MicroSectors FANG+ Index -3X Inverse Leveraged ETNs due January 8, 2038 FNGD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-3,427
Closed -$253K – 1956
2026
Q1
$253K Buy
3,427
+2,019
+143% +$127K 0.03% 901
2025
Q4
$74.2K Buy
+1,408
New +$68.4K 0.01% 1018
2025
Q2
– Sell
-1,493
Closed -$272K – 1689
2025
Q1
$272K Sell
1,493
-2,523
-63% -$350K 0.04% 660
2024
Q4
$549K Buy
+4,016
New +$684K 0.07% 336
2024
Q1
– Sell
-171
Closed -$100K – 3164
2023
Q4
$100K Buy
171
+47
+38% +$36.7K ﹤0.01% 2517
2023
Q3
$123K Sell
124
-20
-14% -$17.7K ﹤0.01% 2367
2023
Q2
$129K Buy
+144
New +$217K ﹤0.01% 2290
2021
Q4
– Sell
-40
Closed -$207K – 1710
2021
Q3
$207K Buy
+40
New +$197K 0.01% 1223

Other funds holding FNGD

Two Sigma Securities's FNGD Position: Q2 2026 in Review

Two Sigma Securities sold out of MicroSectors FANG+ Index -3X Inverse Leveraged ETNs due January 8, 2038 (FNGD) in Q2 2026, closing a stake of 3,427 shares — an estimated $253K sold.

Two Sigma Securities first reported a position in FNGD in Q3 2021 and held it in 8 quarters. The position peaked at $549K in Q4 2024. 9 funds tracked by Wall St. Rank hold FNGD as of Q2 2026.

  • Two Sigma Securities reported no remaining MicroSectors FANG+ Index -3X Inverse Leveraged ETNs due January 8, 2038 position as of Q2 2026 after selling out during the quarter.
  • Two Sigma Securities sold 3,427 MicroSectors FANG+ Index -3X Inverse Leveraged ETNs due January 8, 2038 shares in Q2 2026, an estimated $253K.
  • Two Sigma Securities first reported a position in MicroSectors FANG+ Index -3X Inverse Leveraged ETNs due January 8, 2038 in Q3 2021 and held it in 8 quarters.
  • Two Sigma Securities's MicroSectors FANG+ Index -3X Inverse Leveraged ETNs due January 8, 2038 position peaked at $549K in Q4 2024.
  • 9 funds tracked by Wall St. Rank held MicroSectors FANG+ Index -3X Inverse Leveraged ETNs due January 8, 2038 as of Q2 2026.

Based on Two Sigma Securities's 13F filing for Q2 2026, filed 14 Aug 2026.